Please login to the form below

Not currently logged in
Email:
Password:

prescription drugs

This page shows the latest prescription drugs news and features for those working in and with pharma, biotech and healthcare.

Takeda divests over-the-counter and prescription drugs to Stada for $660m

Takeda divests over-the-counter and prescription drugs to Stada for $660m

Japanese drug-maker Takeda has entered an agreement with German pharma Stada to divest a portfolio of select over-the-counter (OTC) and prescription drugs for a total value of $660m. . ... In October, Takeda announced that it had agreed to divest a

Latest news

More from news
Approximately 2 fully matching, plus 174 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    11. Buvidal – an advance in opioid dependence treatment. Opioid addiction has surged in the US since the 1990s, when prescription drugs such as OxyContin and Vicodin became a common remedy for ... Now there is a growing need for treatments which can

  • Behaviour change – a missing ingredient? Behaviour change – a missing ingredient?

    There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example.So why is it that some of us ... For example, providing prescription drugs in different colours to encourage adherence, or

  • US health reforms US health reforms

    In a very real way, the cost of drugs in US - the only developed nation without some form of cost control - can affect the global marketplace. ... Several studies have shown that the United States spends considerably more per capita on prescription drugs

  • Re-awakening the emotion in healthcare communications Re-awakening the emotion in healthcare communications

    phrases. For healthcare companies, it was the same. However, it started to change when the ABPI established the Prescription Medicines Code of Practice Authority (PMCPA) in 1993 to operate the Code ... At the time, they knew the campaign would test the

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    The accompanying figure summarises the measures that target spending on prescription drugs. ... Governments have typically begun by exploring opportunities to negotiate lower prices for orphan drugs.

More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics